{"name": "10010", "snippets": [{"file_id": "10010", "start": "285", "end": "297", "text": "brodalumab 210 mg every 2 weeks after receiving ustekinumab through 52 weeks", "has_drug": [{"text": "brodalumab", "maps_to": "C3491331:brodalumab", "start": 0, "end": 10, "has_strength": ["210 mg"], "has_frequency": ["every 2 weeks"], "has_negation": "affirmed"}, {"text": "ustekinumab", "maps_to": "C1608841:ustekinumab", "start": 48, "end": 59, "has_duration": ["52 weeks"], "has_negation": "affirmed"}], "has_relation": "before (C1608841->C3491331)"}, {"file_id": "10010", "start": "312", "end": "391", "text": "methotrexate 400 mg without citrovorum factor 100 mg", "has_drug": [{"text": "methotrexate", "maps_to": "C0025677:methotrexate", "start": 0, "end": 12, "has_strength": ["400 mg"], "has_negation": "affirmed"}, {"text": "citrovorum factor", "maps_to": "C2721771:citrovorum factor", "start": 28, "end": 45, "has_strength": ["100 mg"], "has_negation": "negated"}], "has_relation": "without (C0025677->C2721771)"}]}